Latest News

Gerard Sanacora, MD, PhD, George D. and Esther S. Gross Professor of Psychiatry, spoke to The Wall Street Journal about ketamine's effect on the brain and why it can work as an antidepressant.

Announcing the winners of the 2024 Yale School of Medicine teaching awards.

Gerard Sanacora, MD, PhD, George D. and Esther S. Gross Professor of Psychiatry; and Sina Nikayin, MD, assistant professor of psychiatry, are featured in the first episode of a four-part Double Take video miniseries on depression from the New England Journal of Medicine.

Ebony Dix, MD, assistant professor of psychiatry, spoke to Yale Medicine about treating patients who suffer from Long COVID, which physicians say is difficult to diagnose.

Samuel Wilkinson, MD, associate professor of psychiatry and associate director of the Yale Depression Research Program, writes in Psychology Today about the history of ketamine, its use to treat depression, and how it compares to esketamine.

Henrique Oliva, MD, PhD, postdoctoral associate; Gustavo A. Angarita, MD, MHS, assistant professor of psychiatry, and Yale colleagues conducted comprehensive meta-analysis on spine density as it relates to substance use. The findings were published in Molecular Psychiatry.

Gerard Sanacora, MD, PhD, George D. and Esther S. Gross Professor of Psychiatry and director of the Yale Depression Research Program, spoke to CNN about the use of ketamine to treat anxiety and depression.

Samuel T. Wilkinson, MD, associate professor of psychiatry, is author of the new book "Purpose: What Evolution And Human Nature Imply About the Meaning of Our Existence?"

Samuel Wilkinson, MD, associate professor of psychiatry, writes about achievement and maintaining relationships in Time.